drugset / Trial / NCT05391893
Effect of Oral and Intravenous Diltiazem Protocol for Emergency Department Atrial Fibrillation
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The primary objective of the study is to reduce hospital admission and decrease time to disposition through establishing an effective treatment protocol for AF and Atrial Flutter in the Emergency Department of Spectrum Health Lakeland. Secondary outcome is to measure if oral diltiazem is an effective HR controlling agent in AF RVR and Flutter.
Timeline
- Start
- 2020-06-19
- Primary completion
- 2023-04-01
- Completion
- 2023-04-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Diltiazem | Small molecule | 60 mg | Oral |
| Comparator | Amiodarone | Small molecule | — | — |
| Comparator | Digoxin | Other / unclassified | — | — |